Correlation between cell-mediated immunity and degree of infection in subjects living in an endemic area of schistosomiasis.
Cell-mediated immunity to Schistosoma mansoni antigens, unrelated antigens and mitogens was evaluated in 50 subjects with the same degree of exposure to infection living in an endemic area of schistosomiasis. The degree of infection, assessed by the number of eggs/g of stool, was variable in this population (0-5604), suggesting differences in susceptibility to infection. Absence of lymphoproliferative response was observed in 56% of this group, despite having a response to purified protein derivative of tuberculin (PPD) and tetanus toxoid (TT) antigens and to pokeweed mitogen. The 50 subjects were divided into two groups, according to their degree of infection. The lymphoproliferative responses to schistosomula and adult worm antigens in the group with a low degree of infection (< 400 eggs/g of stool) were higher than the ones documented in patients with a high degree of infection (> 400 eggs/g of stool), and these differences were statistically significant (p < 0.001). An inverse correlation between the lymphocyte proliferation in response to S. mansoni antigens and the degree of infection was also observed (p = 0.02), indicating that subjects with a lower degree of infection have a higher lymphoproliferative response to schistosomula and adult worm antigens. No differences in the lymphocyte reactivity to other antigens (PPD and TT) were detected in these groups. An impairment of interferon-gamma in vitro production was observed when the lymphocytes from these subjects were stimulated with S. mansoni adult worm antigen, although they produced gamma interferon in response to phytohemagglutinin.
de Jesus
A M
AM
Department of Medicine University of Bahia, Salvador, Brazil.
Almeida
R P
RP
Bacellar
O
O
Araujo
M I
MI
Demeure
C
C
Bina
J C
JC
Dessein
A J
AJ
Carvalho
E M
EM
D000293:Adolescent; D000328:Adult; D000947:Antigens, Helminth / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007371:Interferon-gamma / Q000096:biosynthesis; D008213:Lymphocyte Activation; D008297:Male; D010073:Oxamniquine / Q000494:pharmacology / Q000627:therapeutic use; D012555:Schistosomiasis mansoni / Q000188:drug therapy / Q000276:immunology*
D000947:Antigens, Helminth; D010073:Oxamniquine; D007371:Interferon-gamma